{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Sacramento",
      "state": "CA",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "95714",
      "recalling_firm": "Boulla LLC",
      "address_1": "2108 N ST #7929",
      "address_2": "",
      "postal_code": "95816",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide within the United States",
      "recall_number": "D-0086-2025",
      "product_description": "ZapMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZapMax, 2108 N St. Sacramento, CA 95816, www.zapmax.com",
      "product_quantity": "Unknown",
      "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.",
      "recall_initiation_date": "20241104",
      "center_classification_date": "20241202",
      "report_date": "20241211",
      "code_info": "Lot #: YZM240406, Exp: 04/05/2027",
      "more_code_info": ""
    }
  ]
}